The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea

Sleep and Breathing

Volumn 16, Issue 2, 2012, Pages 499-504

  Alzoghaibi, Mohammed A ^a   BaHammam, Ahmed S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

CPAP; Obstructive sleep apnea; Oxidative stress; Reactive oxygen species; Superoxide dismutase; Thiobarbituric acid reactive substances

Indexed keywords

LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; APNEA HYPOPNEA INDEX; ARTICLE; BIOSENSOR; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; ENZYME ACTIVITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MALE; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULSE OXIMETER; SLEEP APNEA SYNDROME; THERAPY EFFECT;

ADULT; ANTIOXIDANTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84861479717     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0531-z     Document Type: Article

References (34)

1. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research (1999) The report of an American academy of sleep medicine task force. Sleep 22(5):667-689
2. Selim B, Won C, Yaggi HK (2010) Cardiovascular consequences of sleep apnea. Clin Chest Med 31(2):203-220
3. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4(3):225-228 (Pubitemid 36748608)
4. Halliwell B (1993) The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23(Suppl 1):118-126
5. Mugge A (1998) The role of reactive oxygen species in atherosclerosis. Z Kardiol 87(11):851-864
6. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT (1998) Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273(19):11619-11624 (Pubitemid 28272061)
7. Shi H (2009) Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem 16(34):4593-4600
8. Wali SO, Bahammam AS, Massaeli H, Pierce GN, Iliskovic N, Singal PK, Kryger MH (1998) Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 21(3):290-296 (Pubitemid 128470606)
9. Ozturk L, Mansour B, Yuksel M, Yalcin AS, Celikoglu F, Gokhan N (2003) Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 332(1-2):83-88 (Pubitemid 36577493)
10. AlzoghaibiMA, Bahammam AS (2005) Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 9(3):119-126 (Pubitemid 44193442)
11. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644-647
12. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123-128 (Pubitemid 43906323)
13. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204-210 (Pubitemid 34113817)
14. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68-73 (Pubitemid 36070935)
15. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P, Bouros D (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 132(3):843-851
16. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134(4):686-692
17. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA (2002) Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165(7):950-953 (Pubitemid 34774663)
18. Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2):87-91 (Pubitemid 39302489)
19. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38(6):1395-1399 (Pubitemid 34033422)
20. Touyz RM (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44(3):248-252
21. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD (1991) Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 99(4):861-866
22. Rechtschaffen A (1968) A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. NIH Publication 204, Public Health Service, US Government Printing Office
23. Bonnet M, Carley D, Carskadon M, Easton P (1992) EEG arousals: scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the American Sleep Disorders Association. Sleep 15(2):173-184
24. Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester
25. Jentzsch AM, Bachmann H, Furst P, Biesalski HK (1996) Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20(2):251-256 (Pubitemid 26021882)
26. Paoletti F, Mocali A (1990) Determination of superoxide dismutase activity by purely chemical system based on NAD(P) H oxidation. Methods Enzymol 186:209-220 (Pubitemid 20279958)
27. Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33(5):1195-1205
28. Jelic S, Le Jemtel TH (2008) Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 18(7):253-260
29. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566-570 (Pubitemid 30647201)
30. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26(22):2435-2439 (Pubitemid 41552973)
31. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122(4):1162-1167 (Pubitemid 35339525)
32. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41:1281-1286 (Pubitemid 36706078)
33. Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, Redon J (2004) Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens 17(9):809-816 (Pubitemid 39201097)
34. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti G, Magagna A, Salvetti A (2003) Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 41(4):950-955 (Pubitemid 36418471)